Irinotecan hydrochloride trihydrate
 
       Product #:
        
         TL0473
         
        
        
       
       Image 
       SKU-Pack Size 
       Stock 
       Price($) 
       Quantity 
       
         
        
        
       
       -  
         
 
             
            -            
                                
                  
                   TL0473-25MG
 
                   In stock
                
                    
                                 
                           
                            36.8
                                         
                    
                     
                   
                     
                        
                         -
                        
                        
                         +
                        
 
                       
                    
                 
                                
                  
                   TL0473-100MG
 
                   In stock
                
                    
                                 
                           
                            68.6
                                         
                    
                     
                   
                     
                        
                         -
                        
                        
                         +
                        
 
                       
                    
                 
                                
                  
                   TL0473-250MG
 
                   In stock
                
                    
                                 
                           
                            137
                                         
                    
                     
                   
                     
                        
                         -
                        
                        
                         +
                        
 
                       
                    
                 
                                
                  
                   TL0473-1G
 
                   In stock
                
                    
                                 
                           
                            363.4
                                         
                    
                     
                   
                     
                        
                         -
                        
                        
                         +
                        
 
                       
                    
                 
                           
        
             
            
     
       
         
 
           
      
 
       
      
          
      
 
       
       
       
        
        
Details
 
       
              
          l  General Information  | 
Product Name  | Irinotecan hydrochloride trihydrate  | 
General description  | Irinotecan, a prodrug, is converted to a biologically active metabolite SN-38 by a carboxylesterase converting enzyme.  | 
Synonym  | Irinotecan monohydrochloride trihydrate; Irinotecan HCl Trihydrate; CPT-11  | 
Purity  | ≥99.0%(HPLC)  | CAS Number  | 136572-09-3  | 
Formula  | C33H45ClN4O9  | Molecular Weight  | 677.18  | 
Suitability  | BioReagent, suitable for cell culture, etc.  | 
l  Physical and Chemical Information  | 
Appearance  | Pale yellow to yellow solid  | 
Solubility(25℃)  | DMSO  | ≥50mg/mL  | 
Ethanol  | Slightly soluble  | 
Water  | Slightly soluble  | 
l  Biological Information  | 
Biochem/Physiol   Actions  | Irinotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.  | 
Application  | 1.    Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. 2.    Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. 3.    Topoisomerase I Inhibitors Compounds that inhibit the activity of DNA Topoisomerase I.  | 
l  Packaging & Storage  | 
Packaging  | 25mg; 100mg; 250mg; 1g  | 
Storage temp.  | -20℃  | 
l  Precautions and Disclaimer  | 
This   product is for R&D use only, not for drug, household, or other uses.  | 
l  References  | 
1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov  |